Genetic Profile Predicts Who Will Benefit From Wegovy

Published on May 20, 2024

Certain genes may identify patients with obesity who are most likely to respond strongly to Novo Nordisk’s weight-loss drug Wegovy, researchers reported on Monday. The study, released at the Digestive Disease Week meeting in Washington, found a 95% likelihood that patients…

Read Full Article (External Site)